Cardiovascular Disease and Vascular Engineering

Dear Colleagues,

Cardiovascular diseases are the leading cause of death globally, imposing a significant health burden. In addition to conventional medication, a considerable proportion of patients require alternative interventions by revascularisation and regeneration approaches, which drives innovations in this field. As a result, many advances have been made towards the application of stem cell biology, tissue engineering, material science, and biofabrications. However, despite effort, challenges remain. Areas including but not limited to the cell type, seeding method, biocompatibility of scaffolds, immune response, fabrication techniques, mechanical strengths, and lifespan of implants are waiting to be significantly further improved. It is still not possible to create a tissue-engineered vascular conduit that fits all patient demands, especially small-diameter vascular grafts used for the coronary bypass operation. In situ vascularisation to repair ischemic tissue damage is also challenging. This Special Issue thus aims to highlight recent developments and advances in the application of engineering and regeneration approaches for the treatment of cardiovascular diseases with a focus on vascular interventions. Additionally, basic studies in understanding the pathophysiological processes of cardiovascular disease at a cellular and molecular level, which have the potential of translation for regeneration or engineering, are areas of interest. Areas in basic stem-cell research related to vascular regeneration are also welcome.

Prof. Dr. Tao Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.